pre-seed
Stage
About
Passkey Therapeutics develops a computational genetics-based platform to identify synergistic combinations of approved drugs for treating complex diseases, enabling direct clinical testing of these combinations and bypassing traditional preclinical development.
Explore Passkey Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.